. . . . . . . "[In luminal breast cancers, higher ESPL1 expression was associated with poor-prognosis criteria (age�?�50�years, ductal type, advanced stage, large tumor size, lymph node-positive status, high grade, PR-negative status, luminal B subtype) and with poor metastasis-free survival in both uni- and multivariate analyses.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:17:48+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .